268 related articles for article (PubMed ID: 32611638)
1. Minimal manifestation status and prednisone withdrawal in the MGTX trial.
Lee I; Kuo HC; Aban IB; Cutter GR; McPherson T; Kaminski HJ; Sussman J; Ströbel P; Oger J; Cea G; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BRF; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Verschuuren JJG; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Minisman G; Sonett JR; Wolfe GI;
Neurology; 2020 Aug; 95(6):e755-e766. PubMed ID: 32611638
[TBL] [Abstract][Full Text] [Related]
2. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.
Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BRF; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Verschuuren JJGM; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Silvestri NJ; Conwit R; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
Lancet Neurol; 2019 Mar; 18(3):259-268. PubMed ID: 30692052
[TBL] [Abstract][Full Text] [Related]
3. Randomized Trial of Thymectomy in Myasthenia Gravis.
Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
[TBL] [Abstract][Full Text] [Related]
4. [Thymectomy in thymomatous and non-thymomatous myasthenia gravis: analysis of a cohort of 46 patients].
Cabrera-Maqueda JM; Alba-Isasi MT; Hernández R; Arroyo-Tristán A; Morales-Ortiz A
Rev Neurol; 2020 Mar; 70(6):213-219. PubMed ID: 32149381
[TBL] [Abstract][Full Text] [Related]
5. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
Ponseti JM; Gamez J; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Armengol M
Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724
[TBL] [Abstract][Full Text] [Related]
6. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.
Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Gamez J; Armengol M
Curr Med Res Opin; 2006 May; 22(5):885-95. PubMed ID: 16709310
[TBL] [Abstract][Full Text] [Related]
7. Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.
Kuks JB; Oosterhuis HJ; Limburg PC; The TH
J Autoimmun; 1991 Apr; 4(2):197-211. PubMed ID: 1883480
[TBL] [Abstract][Full Text] [Related]
8. [The Significance of Extended Thymectomy in Non-Thymomatous Myasthenia Gravis: an MGTX Study].
Yoshikawa H
Brain Nerve; 2017 Jan; 69(1):51-59. PubMed ID: 28126978
[TBL] [Abstract][Full Text] [Related]
9. Eight-year follow-up of patients with myasthenia gravis after thymectomy.
Yu S; Li F; Chen B; Lin J; Yang M; Fu X; Li J; Bu B
Acta Neurol Scand; 2015 Feb; 131(2):94-101. PubMed ID: 25170783
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of thymectomy plus prednisone compares with prednisone monotherapy for the treatment of non-thymomatous Myasthenia Gravis: Protocol for a systematic review.
Yang H; Liu D; Hong X; Sun H; Zheng Y; Yang B; Wang W
Medicine (Baltimore); 2020 Jun; 99(25):e20832. PubMed ID: 32569233
[TBL] [Abstract][Full Text] [Related]
11. Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapy.
Wolfe GI; Kaminski HJ; Jaretzki A; Swan A; Newsom-Davis J
Ann N Y Acad Sci; 2003 Sep; 998():473-80. PubMed ID: 14592916
[TBL] [Abstract][Full Text] [Related]
12. Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone.
Newsom-Davis J; Cutter G; Wolfe GI; Kaminski HJ; Jaretzki A; Minisman G; Aban I; Conwit R
Ann N Y Acad Sci; 2008; 1132():344-7. PubMed ID: 18567886
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study.
McPherson T; Aban I; Duda PW; Farzaneh-Far R; Wolfe GI; Kaminski HJ; Cutter G; Lee I;
Muscle Nerve; 2020 Aug; 62(2):261-266. PubMed ID: 32369631
[TBL] [Abstract][Full Text] [Related]
14. [International project--MGTX study].
Yoshikawa H
Rinsho Shinkeigaku; 2007 Nov; 47(11):880-2. PubMed ID: 18210825
[TBL] [Abstract][Full Text] [Related]
15. Transsternal thymectomy for myasthenia gravis: surgical outcome.
Kattach H; Anastasiadis K; Cleuziou J; Buckley C; Shine B; Pillai R; Ratnatunga C
Ann Thorac Surg; 2006 Jan; 81(1):305-8. PubMed ID: 16368387
[TBL] [Abstract][Full Text] [Related]
16. Optimal timing of thymectomy in nonthymomatous myasthenia gravis patients in China: A prospective study.
Pan J; Jiang Q; Liu F; Wen Y
Medicine (Baltimore); 2018 Sep; 97(38):e12499. PubMed ID: 30235757
[TBL] [Abstract][Full Text] [Related]
17. Late-onset myasthenia gravis successfully treated with local resection of cervical ectopic thymoma.
Sekiguchi T; Yoshida K; Minamihara Y; Hayashi H; Oka T; Orimo S
J Clin Neurosci; 2020 Mar; 73():321-323. PubMed ID: 31926660
[TBL] [Abstract][Full Text] [Related]
18. Robotic thymectomy for myasthenia gravis with or without thymoma-surgical and neurological outcomes.
Kumar A; Goyal V; Asaf BB; Trikha A; Sood J; Vijay CL
Neurol India; 2017; 65(1):58-63. PubMed ID: 28084239
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
20. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]